SG11201504701UA - Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins - Google Patents
Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteinsInfo
- Publication number
- SG11201504701UA SG11201504701UA SG11201504701UA SG11201504701UA SG11201504701UA SG 11201504701U A SG11201504701U A SG 11201504701UA SG 11201504701U A SG11201504701U A SG 11201504701UA SG 11201504701U A SG11201504701U A SG 11201504701UA SG 11201504701U A SG11201504701U A SG 11201504701UA
- Authority
- SG
- Singapore
- Prior art keywords
- elements
- immunogenic composition
- difficile cdtb
- cdta proteins
- cdta
- Prior art date
Links
- 241000193163 Clostridioides difficile Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1223342.5A GB201223342D0 (en) | 2012-12-23 | 2012-12-23 | Immunogenic composition |
| PCT/EP2013/077762 WO2014096393A1 (en) | 2012-12-23 | 2013-12-20 | Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504701UA true SG11201504701UA (en) | 2015-07-30 |
Family
ID=47682553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504701UA SG11201504701UA (en) | 2012-12-23 | 2013-12-20 | Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins |
Country Status (12)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011298306B2 (en) | 2010-09-03 | 2017-10-19 | Valneva Austria Gmbh | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof |
| TWI671313B (zh) | 2011-04-22 | 2019-09-11 | 惠氏有限責任公司 | 與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法 |
| RU2014127714A (ru) * | 2011-12-08 | 2016-01-27 | Новартис Аг | ВАКЦИНА НА ОСНОВЕ ТОКСИНОВ Clostridium difficile |
| BR122016023101B1 (pt) * | 2012-10-21 | 2022-03-22 | Pfizer Inc | Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile |
| PL3160500T3 (pl) * | 2014-06-25 | 2020-02-28 | Glaxosmithkline Biologicals S.A. | Immunogenna kompozycja clostridium difficile |
| MX2019010948A (es) * | 2017-03-15 | 2020-01-09 | Novavax Inc | Métodos y composiciones para inducir respuestas inmunitarias contra clostridium difficile. |
| US10933126B2 (en) | 2018-05-03 | 2021-03-02 | The Board Of Regents Of The University Of Oklahoma | Clostridium difficile immunogenic compositions and methods of use |
| MX2020013623A (es) | 2018-06-19 | 2021-03-25 | Glaxosmithkline Biologicals Sa | Composicion inmunogenica. |
| CN111793130B (zh) * | 2019-03-20 | 2021-09-14 | 华中农业大学 | 一株副猪嗜血杆菌CdtB杂交瘤细胞及单克隆抗体应用 |
| GB202205833D0 (en) | 2022-04-21 | 2022-06-08 | Glaxosmithkline Biologicals Sa | Bacteriophage |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX348670B (es) * | 2009-02-11 | 2017-06-23 | Cedars Sinai Medical Center | Anticuerpo contra toxina de distensión citoletal de campylobacter jejuni. |
| WO2011060431A2 (en) * | 2009-11-16 | 2011-05-19 | University Of Maryland Baltimore | Multivalent live vector vaccine against clostridium difficile-associated disease |
| AU2011298306B2 (en) * | 2010-09-03 | 2017-10-19 | Valneva Austria Gmbh | Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof |
| AR089797A1 (es) * | 2012-01-27 | 2014-09-17 | Merck Sharp & Dohme | Vacunas contra clostridum difficile que comprenden toxinas recombinantes |
-
2012
- 2012-12-23 GB GBGB1223342.5A patent/GB201223342D0/en not_active Ceased
-
2013
- 2013-12-20 AU AU2013366450A patent/AU2013366450A1/en not_active Abandoned
- 2013-12-20 CA CA2894951A patent/CA2894951C/en active Active
- 2013-12-20 SG SG11201504701UA patent/SG11201504701UA/en unknown
- 2013-12-20 AR ARP130105022A patent/AR094275A1/es unknown
- 2013-12-20 WO PCT/EP2013/077762 patent/WO2014096393A1/en active Application Filing
- 2013-12-20 EP EP13817931.2A patent/EP2934579B1/en active Active
- 2013-12-20 US US14/653,989 patent/US9669083B2/en active Active
- 2013-12-20 CN CN201380073503.5A patent/CN105120892B/zh active Active
- 2013-12-20 ES ES13817931T patent/ES2748054T3/es active Active
- 2013-12-20 JP JP2015548649A patent/JP6515036B2/ja not_active Expired - Fee Related
- 2013-12-20 BR BR112015014727A patent/BR112015014727B8/pt not_active IP Right Cessation
-
2017
- 2017-05-15 US US15/595,651 patent/US20180043005A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013366450A1 (en) | 2015-07-23 |
| JP2016504993A (ja) | 2016-02-18 |
| JP6515036B2 (ja) | 2019-05-15 |
| WO2014096393A1 (en) | 2014-06-26 |
| CA2894951A1 (en) | 2014-06-26 |
| EP2934579B1 (en) | 2019-08-07 |
| BR112015014727B1 (pt) | 2022-08-02 |
| CN105120892B (zh) | 2020-07-31 |
| EP2934579A1 (en) | 2015-10-28 |
| US20150313985A1 (en) | 2015-11-05 |
| CA2894951C (en) | 2023-05-09 |
| US20180043005A1 (en) | 2018-02-15 |
| CN105120892A (zh) | 2015-12-02 |
| BR112015014727B8 (pt) | 2022-09-20 |
| BR112015014727A2 (pt) | 2017-10-10 |
| US9669083B2 (en) | 2017-06-06 |
| ES2748054T3 (es) | 2020-03-12 |
| AR094275A1 (es) | 2015-07-22 |
| GB201223342D0 (en) | 2013-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical preparations containing them | |
| SG11201504701UA (en) | Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins | |
| ZA201406250B (en) | Compositions of glp-1 peptides and preparation thereof | |
| IL252566A0 (en) | Pharmacy preparations and methods | |
| PL2996494T3 (pl) | Kompozycje i artykuły spożywcze | |
| IL237461A0 (en) | New flavor compounds with improved taste and/or shelf life | |
| IL251120B (en) | Immunogenic/therapeutic glycoside preparations and their uses | |
| ZA201501124B (en) | Trans-clomiphene formulations and uses thereof | |
| IL239840A0 (en) | Polymyxins, preparations, methods of preparation and methods of use | |
| EP2929787A4 (en) | FOOD COMPOSITION AND MOLLE CAPSULE CONTAINING THE SAME | |
| IL234695A0 (en) | Antigen compositions and methods | |
| EP3074028A4 (en) | Activity enhancing curcumin compositions and methods of use | |
| GB201400431D0 (en) | Phospholipid compositions and their preparation | |
| GB201215380D0 (en) | Methods and compositions | |
| SG11201510166YA (en) | Compositions and methods of immunizing against c. difficile | |
| EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
| EP2852370A4 (en) | FLASH-CONTAINING COMPOSITIONS AND METHODS OF USE | |
| IL244537A0 (en) | New administration preparations and methods of their use | |
| GB201208315D0 (en) | Pharmaceutical methods and compositions | |
| EP2945703A4 (en) | ALBU-BCHE FORMULATIONS, PREPARATION THEREOF AND USES THEREOF | |
| EP2808019A4 (en) | IMPROVED NITAZOXANIDE COMPOSITION AND PROCESS FOR PREPARING THE SAME | |
| IL234228B (en) | Compositions of glp-1 peptides and preparation thereof | |
| IL234614B (en) | Pharmaceutical composition and preparation method thereof | |
| AU2013904774A0 (en) | Methods and Preparation and Use of Xanthorrhoeaceae Compositions | |
| AU2012905317A0 (en) | Methods and Preparation and Use of Xanthorrhoeaceae Compositions |